{"id":42,"date":"2019-01-27T10:42:21","date_gmt":"2019-01-27T09:42:21","guid":{"rendered":"http:\/\/bogenommedicinskcannabis.dk\/?page_id=42"},"modified":"2019-05-04T07:50:09","modified_gmt":"2019-05-04T06:50:09","slug":"referencer-kapitel-5","status":"publish","type":"page","link":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/referencer-kapitel-5\/","title":{"rendered":"Referencer – Kapitel 5"},"content":{"rendered":"\r\n

[524]<\/sup><\/a>\u00a010 Cannabis-Based Drugs Produced By Big Pharma.\u00a0https:\/\/herb.co\/marijuana\/news\/cannabis-based-drugs-big-pharma<\/a><\/p>\r\n\r\n\r\n\r\n

[525]<\/sup><\/a>\u00a0Dagfinn Haarr, Sofie Haughom: Marihuana er effektiv medisin.http:\/\/www.aftenposten.no\/meninger\/kronikker\/Kronikk-Marihuana-er-effektiv-medisin—Dagfinn-Haarr_-Sofie-Haughom-8378238.html<\/a><\/p>\r\n\r\n\r\n\r\n

[526]<\/sup><\/a>\u00a0Cannabis f\u00e5r kr\u00e6ftceller til at beg\u00e5 selvmord.\u00a0http:\/\/www.ladanesa.com\/temaadebat\/43-nyheder\/temaadebat\/4818-cannabis-far-kraeftceller-til-at-bega-selvmord<\/a><\/p>\r\n\r\n\r\n\r\n

[527]<\/sup><\/a>\u00a0What Are The Medical Benefits of Marijuana?\u00a0https:\/\/www.leafscience.com\/2017\/10\/13\/medical-benefits-marijuana\/<\/a><\/p>\r\n\r\n\r\n\r\n

What Exactly Is Unconstitutional About Plans To Limit THC?\u00a0https:\/\/herb.co\/marijuana\/news\/what-exactly-is-unconstitutional-about-plans-to-limit-thc<\/a><\/p>\r\n\r\n\r\n\r\n

What is Sativex (Nabiximols).https:\/\/www.leafscience.com\/2017\/11\/02\/what-is-sativex-nabiximols\/<\/a><\/p>\r\n\r\n\r\n\r\n

John M. McPartland, Ethan B. Russo: Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?\u00a0https:\/\/www.cannabis-med.org\/data\/pdf\/2001-03-04-7.pdf<\/a><\/p>\r\n\r\n\r\n\r\n

[528]<\/sup><\/a>\u00a0Howard P, Twycross R, Shuster J, et al.: Cannabinoids. J Pain Symptom Manage 46 (1): 142-9, 2013.\u00a0[PUBMED Abstract]<\/a>.\u00a0http:\/\/www.cancer.gov\/about-cancer\/treatment\/cam\/hp\/cannabis-pdq#link\/_45_toc<\/a><\/p>\r\n\r\n\r\n\r\n

[529]<\/sup><\/a>\u00a0Ordination af medicinsk cannabis.\u00a0https:\/\/www.sundhed.dk\/sundhedsfaglig\/information-til-praksis\/sjaelland\/almen-praksis\/laegemidler\/medicinsk-cannabis\/<\/a><\/p>\r\n\r\n\r\n\r\n

[530]<\/sup><\/a>\u00a0Derick T Wade<\/a>,\u00a0Christine Collin<\/a>,\u00a0Colin Stott<\/a>\u00a0et al.:\u00a0Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Multiple Sclerosis Journal Vol 16, Issue 6, 2010.\u00a0http:\/\/journals.sagepub.com\/doi\/abs\/10.1177\/135245851036746<\/a><\/p>\r\n\r\n\r\n\r\n

[531]<\/sup><\/a>\u00a0Collin C<\/a>1<\/sup>,\u00a0Davies P<\/a>,\u00a0Mutiboko IK<\/a>. Et al.: Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.\u00a0Eur J Neurol.<\/a>\u00a02007 Mar;14(3):290-6.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17355549<\/a><\/p>\r\n\r\n\r\n\r\n

[532]<\/sup><\/a>\u00a0Portenoy RK<\/a>1<\/sup>,\u00a0Ganae-Motan ED<\/a>,\u00a0Allende S<\/a>. et al.: Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.\u00a0J Pain.<\/a>\u00a02012 May;13(5):438-49. doi: 10.1016\/j.jpain.2012.01.003. Epub 2012 Apr 5.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22483680<\/a><\/p>\r\n\r\n\r\n\r\n

[533]<\/sup><\/a>\u00a06 Takeaways From Dr. Ethan Russo\u2019s \u2018Cannabis: An Unconventional Solution to the Opioid Crisis\u2019.https:\/\/www.leafly.com\/news\/health\/6-takeaways-from-dr-ethan-russos-cannabis-an-unconventional-solution-to-the-opioid-crisis<\/a><\/p>\r\n\r\n\r\n\r\n

What is Sativex (Nabiximols).https:\/\/www.leafscience.com\/2017\/11\/02\/what-is-sativex-nabiximols\/<\/a><\/p>\r\n\r\n\r\n\r\n

[534]<\/sup><\/a>\u00a0Turo J.Nurmikko,<\/a>\u00a0Mick G.Serpell,<\/a>\u00a0BarbaraHoggart<\/a>\u00a0et al.:\u00a0Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial.\u00a0PAIN\u00ae<\/a>\u00a0Volume 133, Issues 1\u20133<\/a>, 15 December 2007, Pages 210-220.\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304395907004642<\/a><\/p>\r\n\r\n\r\n\r\n

[535]<\/sup><\/a>\u00a0Ethan\u2005B. Russo<\/a>,\u00a0Geoffrey\u2005W. Guy<\/a>,\u00a0Philip\u2005J. Robson<\/a>:\u00a0Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of\u00a0Sativex<\/em>\u00ae<\/sup>, a Cannabis\u2010Based Medicine. Chemistry & Diversity\u00a0Volume4, Issue8<\/a>\u00a0August 2007 Pages 1729-1743.\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/cbdv.200790150<\/a><\/p>\r\n\r\n\r\n\r\n

[536]<\/sup><\/a>\u00a0Blake DR<\/a>1<\/sup>,\u00a0Robson P<\/a>,\u00a0Ho M<\/a>. et al.: Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.\u00a0Rheumatology (Oxford).<\/a>\u00a02006 Jan;45(1):50-2. Epub 2005 Nov 9.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16282192<\/a><\/p>\r\n\r\n\r\n\r\n

[537]<\/sup><\/a>\u00a0Kavia RB<\/a>1<\/sup>,\u00a0De Ridder D<\/a>,\u00a0Constantinescu CS<\/a>.\u00a0Et al.: Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.\u00a0Mult Scler.<\/a>\u00a02010 Nov;16(11):1349-59. doi: 10.1177\/1352458510378020. Epub 2010 Sep 9.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20829244<\/a><\/p>\r\n\r\n\r\n\r\n

[538]<\/sup><\/a>\u00a0Berman JS<\/a>1<\/sup>,\u00a0Symonds C<\/a>,\u00a0Birch R<\/a>.: Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial.\u00a0Pain.<\/a>\u00a02004 Dec;112(3):299-306.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15561385<\/a><\/p>\r\n\r\n\r\n\r\n

[539]<\/sup><\/a>\u00a0J\u00fcrgen Koehler<\/a>,\u00a0Wolfgang Feneberg<\/a>,\u00a0Martin Meier<\/a>:\u00a0Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity. Journal\u00a0\u00a0International Journal of Neuroscience\u00a0<\/a>Volume 124, 2014 –\u00a0Issue 9<\/a>.\u00a0https:\/\/www.tandfonline.com\/doi\/abs\/10.3109\/00207454.2013.877460<\/a><\/p>\r\n\r\n\r\n\r\n

[540]<\/sup><\/a>\u00a0Marijuana and Anxiety: A Guide.\u00a0https:\/\/www.leafscience.com\/2017\/05\/10\/marijuana-and-anxiety-a-guide\/<\/a><\/p>\r\n\r\n\r\n\r\n

[541]<\/sup><\/a>\u00a0Why Does Marijuana Make You Paranoid?\u00a0https:\/\/www.leafscience.com\/2017\/09\/05\/marijuana-make-paranoid\/<\/a><\/p>\r\n\r\n\r\n\r\n

[542]<\/sup><\/a>\u00a0Sativex Oromucosal Spray.\u00a0https:\/\/www.medicines.org.uk\/emc\/medicine\/23262<\/a><\/p>\r\n\r\n\r\n\r\n

[543]<\/sup><\/a>\u00a0GW\u2019s Epidiolex\u00ae<\/sup>\u00a0Clinical Program.\u00a0https:\/\/www.gwpharm.com\/epilepsy-patients-caregivers\/patients<\/a><\/p>\r\n\r\n\r\n\r\n

[544]<\/sup><\/a>\u00a0https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210365lbl.pdf<\/a><\/p>\r\n\r\n\r\n\r\n

GW Announces New Epidiolex\u00ae (CBD) Positive Phase 3 Data in Dravet Syndrome and Lennox-Gastaut Syndrome.\u00a0http:\/\/ir.gwpharm.com\/releasedetail.cfm?releaseid=1002552<\/a><\/p>\r\n\r\n\r\n\r\n

[545]<\/sup><\/a>\u00a0Marijuana and muscle spasms.\u00a0https:\/\/herb.co\/marijuana\/news\/marijuana-and-muscle-spasms<\/a><\/p>\r\n\r\n\r\n\r\n

How to Use Cannabis Tincture.\u00a0https:\/\/zenpype.com\/how-to-use-cannabis-tincture\/<\/a><\/p>\r\n\r\n\r\n\r\n

Medical Marijuana and Epilepsy.\u00a0https:\/\/www.epilepsy.com\/learn\/treating-seizures-and-epilepsy\/other-treatment-approaches\/medical-marijuana-and-epilepsy<\/a><\/p>\r\n\r\n\r\n\r\n

[546]<\/sup><\/a>\u00a0FDA and Marijuana: Questions and Answers.\u00a0https:\/\/www.fda.gov\/newsevents\/publichealthfocus\/ucm421168.htm#use<\/a><\/p>\r\n\r\n\r\n\r\n

Three Different Cannabinoid-Based Medicines Approved by the FDA\u00a0https:\/\/www.medicaljane.com\/2017\/05\/01\/the-3-cannabis-based-medicines-approved-by-the-fda\/<\/a><\/p>\r\n\r\n\r\n\r\n

[547]<\/sup><\/a>\u00a0What is THC (Tetrahydrocannabinol)?https:\/\/www.leafscience.com\/2017\/11\/09\/what-is-thc-tetrahydrocannabinol\/<\/a><\/p>\r\n\r\n\r\n\r\n

[548]<\/sup><\/a>\u00a0Tetrahydrocannabinol (THC).\u00a0https:\/\/www.medicaljane.com\/cannabinoid\/thc\/<\/a><\/p>\r\n\r\n\r\n\r\n

[549]<\/sup><\/a>\u00a0Marinol VS THC: What\u2019s The Difference?\u00a0https:\/\/herb.co\/marijuana\/news\/marinol-vs-thc-whats-difference<\/a><\/p>\r\n\r\n\r\n\r\n

How Is Synthetic Weed Legal When It Kills?\u00a0https:\/\/herb.co\/marijuana\/news\/how-is-synthetic-weed-legal-when-it-kills<\/a><\/p>\r\n\r\n\r\n\r\n

What is Marinol (Dronabinol).https:\/\/www.leafscience.com\/2017\/10\/23\/what-is-marinol-dronabinol\/<\/a><\/p>\r\n\r\n\r\n\r\n

[550]<\/sup><\/a>\u00a0Marinol.\u00a0https:\/\/bodyandhealth.canada.com\/drug\/getdrug\/marinol<\/a><\/p>\r\n\r\n\r\n\r\n

Medical MariJuana: Furthering an Objective Debate. Canadian Journal Addiction. Volume 4 Number 3.\u00a0https:\/\/www.csam-smca.org\/wp-content\/uploads\/2013\/09\/CJA_Journal_September_2013.pdf<\/a><\/p>\r\n\r\n\r\n\r\n

[551]<\/sup><\/a>\u00a0Tram\u00e8r MR<\/a>1<\/sup>,\u00a0Carroll D<\/a>,\u00a0Campbell FA<\/a>. Et al.: Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.\u00a0BMJ.<\/a>\u00a02001 Jul 7;323(7303):16-21.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11440936<\/a><\/p>\r\n\r\n\r\n\r\n

[552]<\/sup><\/a>\u00a0Gorter R, Seefried M, Volberding P: Dronabinol effects on weight in patients with HIV infection. AIDS 6 (1): 127, 1992.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1311935<\/a><\/p>\r\n\r\n\r\n\r\n

Beal JE, Olson R, Laubenstein L, et al.: Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10 (2): 89-97, 1995.\u00a0\u00a0http:\/\/www.cancer.gov\/about-cancer\/treatment\/cam\/hp\/cannabis-pdq#section\/all<\/a><\/p>\r\n\r\n\r\n\r\n

What is Marinol (Dronabinol)?\u00a0https:\/\/www.leafscience.com\/2017\/10\/23\/what-is-marinol-dronabinol\/<\/a><\/p>\r\n\r\n\r\n\r\n

Drugs@FDA: FDA Approved Drug Products.\u00a0https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&applno=018651<\/a><\/p>\r\n\r\n\r\n\r\n

Medical Marijuana vs. Marinol.\u00a0https:\/\/www.marijuanadoctors.com\/blog\/medical-marijuana-vs-marinol\/?utm_content=buffer29bcf&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer<\/a><\/p>\r\n\r\n\r\n\r\n

What Are The Medical Benefits of Marijuana?\u00a0https:\/\/www.leafscience.com\/2017\/10\/13\/medical-benefits-marijuana\/<\/a><\/p>\r\n\r\n\r\n\r\n

Sallan SE, Zinberg NE, Frei E 3rd: Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 293 (16): 795-7, 1975.\u00a0[PUBMED Abstract]<\/a>\u00a0http:\/\/www.cancer.gov\/about-cancer\/treatment\/cam\/hp\/cannabis-pdq#link\/_45_toc<\/a>\u00a0http:\/\/www.cancer.gov\/about-cancer\/treatment\/cam\/hp\/cannabis-pdq#section\/all<\/a><\/p>\r\n\r\n\r\n\r\n

[553]<\/sup><\/a>\u00a0Jeffrey E.Beal, Richard Olson,\u00a0Linda Laubenstein<\/a>\u00a0et al.:\u00a0Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.\u00a0Journal of Pain and Symptom Management<\/a>\u00a0Volume 10, Issue 2<\/a>, February 1995, Pages 89-97.\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/0885392494001174<\/a><\/p>\r\n\r\n\r\n\r\n

[554]<\/sup><\/a>\u00a0Narang S<\/a>1<\/sup>,\u00a0Gibson D<\/a>,\u00a0Wasan AD<\/a>,\u00a0Ross EL<\/a>\u00a0et al.: Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.\u00a0J Pain.<\/a>\u00a02008 Mar;9(3):254-64. Epub 2007 Dec 21.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18088560<\/a><\/p>\r\n\r\n\r\n\r\n

Medical Marijuana and Chronic Pain.\u00a0https:\/\/www.marijuanadoctors.com\/conditions\/chronic-pain\/<\/a><\/p>\r\n\r\n\r\n\r\n

[555]<\/sup><\/a>\u00a0Medical Marijuana and Fibromyalgia.\u00a0https:\/\/www.marijuanadoctors.com\/conditions\/fibromyalgia\/<\/a><\/p>\r\n\r\n\r\n\r\n

Schley M<\/a>1<\/sup>,\u00a0Legler A<\/a>,\u00a0Skopp G<\/a>. et al.: Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief.\u00a0Curr Med Res Opin.<\/a>\u00a02006 Jul;22(7):1269-76.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16834825<\/a><\/p>\r\n\r\n\r\n\r\n

[556]<\/sup><\/a>\u00a0Medical Marijuana and Multiple Sclerosis (MS).\u00a0https:\/\/www.marijuanadoctors.com\/conditions\/multiple-sclerosis-ms\/<\/a><\/p>\r\n\r\n\r\n\r\n

Svendsen KB<\/a>1<\/sup>,\u00a0Jensen TS<\/a>,\u00a0Bach FW<\/a>.: Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.\u00a0BMJ.<\/a>\u00a02004 Jul 31;329(7460):253. Epub 2004 Jul 16. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15258006<\/p>\r\n\r\n\r\n\r\n

[557]<\/sup><\/a>\u00a0Carter GT<\/a>1<\/sup>,\u00a0Abood ME<\/a>,\u00a0Aggarwal SK<\/a>,\u00a0Weiss MD<\/a>: Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.\u00a0Am J Hosp Palliat Care.<\/a>\u00a02010 Aug;27(5):347-56. doi: 10.1177\/1049909110369531. Epub 2010 May 3.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20439484<\/a><\/p>\r\n\r\n\r\n\r\n

Medical Marijuana and Amyotrophic Lateral Sclerosis (ALS).\u00a0https:\/\/www.marijuanadoctors.com\/conditions\/amyotrophic-lateral-sclerosis-als\/<\/a><\/p>\r\n\r\n\r\n\r\n

[558]<\/sup><\/a>\u00a0Prasad B<\/a>1<\/sup>,\u00a0Radulovacki MG<\/a>,\u00a0Carley DW<\/a>: Proof of concept trial of dronabinol in obstructive sleep apnea.\u00a0Front Psychiatry.<\/a>\u00a02013 Jan 22;4:1. doi: 10.3389\/fpsyt.2013.00001. eCollection 2013.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23346060<\/a><\/p>\r\n\r\n\r\n\r\n

Medical Marijuana and Sleep Apnea.\u00a0https:\/\/www.marijuanadoctors.com\/conditions\/sleep-apnea\/<\/a><\/p>\r\n\r\n\r\n\r\n

[559]<\/sup><\/a>\u00a0Volicer L<\/a>1<\/sup>,\u00a0Stelly M<\/a>,\u00a0Morris J<\/a>,\u00a0McLaughlin J<\/a>. et al.: Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease.\u00a0Int J Geriatr Psychiatry.<\/a>\u00a01997 Sep;12(9):913-9.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9309469<\/a><\/p>\r\n\r\n\r\n\r\n

Medical Marijuana and Dementia.\u00a0https:\/\/www.marijuanadoctors.com\/conditions\/dementia\/<\/a><\/p>\r\n\r\n\r\n\r\n

[560]<\/sup><\/a>\u00a0Christine A.,Rabinaka<\/a>\u00a0Mike, Angstadta<\/a>\u00a0Chandra, S.Sripada<\/a>\u00a0et al.:\u00a0Cannabinoid facilitation of fear extinction memory recall in humans.\u00a0Neuropharmacology<\/a>\u00a0Volume 64<\/a>, January 2013, Pages 396-402.\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0028390812003371<\/a><\/p>\r\n\r\n\r\n\r\n

Synthetic THC May Help in the Treatment of Phobias.\u00a0https:\/\/www.medicaljane.com\/2013\/08\/05\/american-study-tetrahydrocannabinol-thc-may-help-phobia-treatment\/<\/a><\/p>\r\n\r\n\r\n\r\n

[561]<\/sup><\/a>\u00a0Ordination af medicinsk cannabis.\u00a0https:\/\/www.sundhed.dk\/sundhedsfaglig\/information-til-praksis\/sjaelland\/almen-praksis\/laegemidler\/medicinsk-cannabis\/<\/a><\/p>\r\n\r\n\r\n\r\n

[562]<\/sup><\/a>\u00a0Medicinsk cannabis og cannabisbaseret medicin\u00a0https:\/\/www.sundhed.dk\/sundhedsfaglig\/laegehaandbogen\/sundhedsoplysning\/sundhedsoplysning\/diverse\/medicinsk-cannabis\/<\/a><\/p>\r\n\r\n\r\n\r\n

[563]<\/sup><\/a>\u00a0Drugs@FDA: FDA Approved Drug Products.\u00a0https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&applno=205525<\/a><\/p>\r\n\r\n\r\n\r\n

[564]<\/sup><\/a>\u00a0Is a maker of deadly painkillers bankrolling the opposition of Arizona marijuana legalization?\u00a0http:\/\/www.thecannabist.co\/2016\/09\/12\/arizona-marijuana-insys-therapeutics\/62986\/<\/a><\/p>\r\n\r\n\r\n\r\n

[565]<\/sup><\/a>\u00a0The non-weed biz world is zeroing in on legalization.\u00a0http:\/\/www.thecannabist.co\/2016\/11\/02\/marijuana-legalization-business-risk-factor-sec-public-companies\/66480\/<\/a><\/p>\r\n\r\n\r\n\r\n

[566]<\/sup><\/a>\u00a0Billionaire John Kapoor of Insys Therapeutics Arrested in Phoenix on Opioid Charges.\u00a0http:\/\/www.phoenixnewtimes.com\/news\/billionaire-john-kapoor-of-insys-therapeutics-arrested-in-phoenix-on-opioid-charges-9813260<\/a><\/p>\r\n\r\n\r\n\r\n

Opioid maker settles lawsuit over fentanyl spray.\u00a0http:\/\/www.unionleader.com\/courts\/Opioid-maker-settles-lawsuit-over-fentanyl-spray-01182017<\/a><\/p>\r\n\r\n\r\n\r\n

http:\/\/www.chicagotribune.com\/business\/ct-subsys-opioid-lawsuit-0826-biz-20160825-story.html<\/a><\/p>\r\n\r\n\r\n\r\n

Attorney General Brings Enforcement Action Against Opioid Pharmaceutical Company Insys Therapeutics For Its Unfair And Deceptive Marketing Practices Of Its Fentanyl Drug Subsys.\u00a0https:\/\/www.doj.nh.gov\/media-center\/press-releases\/2017\/20170118-insys.htm<\/a><\/p>\r\n\r\n\r\n\r\n

Dose of Justice.\u00a0https:\/\/news.vice.com\/en_ca\/article\/bjdw53\/ex-pharma-executives-arrested-for-allegedly-bribing-doctors-to-prescribe-fentanyl<\/a><\/p>\r\n\r\n\r\n\r\n

[567]<\/sup><\/a>\u00a0Insys founder Kapoor sued by New Jersey over opioid marketing campaign.\u00a0https:\/\/www.azcentral.com\/story\/money\/business\/health\/2017\/11\/20\/insys-founder-john-kapoor-sued-new-jersey-over-opioid-marketing-campaign\/880646001\/<\/a><\/p>\r\n\r\n\r\n\r\n

[568]<\/sup><\/a>\u00a0Medicinsk cannabis og cannabisbaseret medicin\u00a0https:\/\/www.sundhed.dk\/sundhedsfaglig\/laegehaandbogen\/sundhedsoplysning\/sundhedsoplysning\/diverse\/medicinsk-cannabis\/<\/a><\/p>\r\n\r\n\r\n\r\n

[569]<\/sup><\/a>\u00a0Drugs@FDA: FDA Approved Drug Products.\u00a0https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&applno=018677<\/a><\/p>\r\n\r\n\r\n\r\n

[570]<\/sup><\/a>\u00a0What is the entourage effect?\u00a0https:\/\/www.medicaljane.com\/question\/what-is-the-weed-entourage-effect-of-medical-marijuana\/<\/a><\/p>\r\n\r\n\r\n\r\n

DR. ETHAN RUSSO: CBD & CLINICAL ENDOCANNABINOID DEFICIENCY\u00a0https:\/\/www.projectcbd.org\/science\/cannabis-pharmacology\/dr-ethan-russo-cbd-clinical-endocannabinoid-deficiency<\/a><\/p>\r\n\r\n\r\n\r\n

[571]<\/sup><\/a>Medicinsk cannabis og cannabisbaseret medicin.\u00a0https:\/\/www.sundhed.dk\/sundhedsfaglig\/laegehaandbogen\/sundhedsoplysning\/sundhedsoplysning\/diverse\/medicinsk-cannabis\/<\/a><\/p>\r\n\r\n\r\n\r\n

[572]<\/sup><\/a>\u00a0Berlach, D. M., Shir, Y., and Ware, M. A. (2006). Experience with the synthetic cannabinoid nabilone in chronic noncancer pain. Pain Med. 7: 25-29.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16533193<\/a><\/p>\r\n\r\n\r\n\r\n

[573]<\/sup><\/a>\u00a0Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D (2008). Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ,336:199. doi: 10.1136\/bmj.39429.619653.80.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18182416<\/a><\/p>\r\n\r\n\r\n\r\n

Toth, C., Mawani, S., Brady, S., Chan, C. and others. (2012). An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain. Pain. 153: 2073-2082.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22921260<\/a><\/p>\r\n\r\n\r\n\r\n

[574]<\/sup><\/a>\u00a0Ware, M. A., Fitzcharles, M. A., Joseph, L., and Shir, Y. (2010). The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.\u00a0Anesth.Analg. 110: 604-610.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20007734<\/a><\/p>\r\n\r\n\r\n\r\n

Skrabek, R. Q., Galimova, L., Ethans, K., and Perry, D. (2008). Nabilone for the treatment of pain in fibromyalgia. J.Pain. 9: 164-173.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17974490<\/a><\/p>\r\n\r\n\r\n\r\n

[575]<\/sup><\/a>\u00a0Fraser, G. A. (2009). The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS.Neurosci.Ther. 15: 84-88.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19228182<\/a><\/p>\r\n\r\n\r\n\r\n

[576]<\/sup><\/a>\u00a0Pooyania, S., Ethans, K., Szturm, T., Casey, A. and others. (2010). A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. Arch.Phys.Med.Rehabil. 91: 703-707.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20434606<\/a><\/p>\r\n\r\n\r\n\r\n

[577]<\/sup><\/a>\u00a0Marinol vs. Natural Plant.\u00a0http:\/\/norml.org\/component\/zoo\/category\/marinol-vs-natural-cannabis<\/a><\/p>\r\n\r\n\r\n\r\n

[578]<\/sup><\/a>\u00a0Cannabis Cannabinoids.\u00a0https:\/\/www.marijuanadoctors.com\/resources\/cannabinoids\/<\/a><\/p>\r\n\r\n\r\n\r\n

[579]<\/sup><\/a>\u00a0Marijuana Terpenes Guide.\u00a0https:\/\/www.marijuanadoctors.com\/resources\/medical-marijuana-terpenes\/<\/a><\/p>\r\n\r\n\r\n\r\n

[580]<\/sup><\/a>\u00a0Russo E<\/a>1<\/sup>,\u00a0Guy GW<\/a>: A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.\u00a0Med Hypotheses.<\/a>\u00a02006;66(2):234-46. Epub 2005 Oct 4.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16209908<\/a><\/p>\r\n\r\n\r\n\r\n

[581]<\/sup><\/a>\u00a0Ethan B Russo<\/a>:\u00a0Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.\u00a0Br J Pharmacol<\/a>. 2011 Aug; 163(7): 1344\u20131364. doi:\u00a0\u00a010.1111\/j.1476-5381.2011.01238.x<\/a>.https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3165946\/<\/a><\/p>\r\n\r\n\r\n\r\n

[582]<\/sup><\/a>\u00a0Physician\u2019s Desk Reference: 43rd edition.<\/em>\u00a0Medical Economics Company. 1989: 1859-1860.<\/p>\r\n\r\n\r\n\r\n

[583]<\/sup><\/a>\u00a0Physician\u2019s Desk Reference: 52nd edition.\u00a0Medical Economics Company. 1998: 2353-2355.<\/p>\r\n\r\n\r\n\r\n

[584]<\/sup><\/a>\u00a0National Academy of Sciences, Institute of Medicine. 1999.\u00a0Marijuana and medicine: Assessing the Science Base.\u00a0p. 203.\u00a01999. Washington, DC: The National Academies Press.\u00a0https:\/\/doi.org\/10.17226\/6376<\/a>\u00a0.<\/p>\r\n\r\n\r\n\r\n

[585]<\/sup><\/a>\u00a0J. Morgan and L. Zimmer,\u00a0Marijuana Myths, Marijuana Facts: A Review of the Scientific Evidence.<\/em>\u00a0The Lindesmith Center. 1997: 18-19.\u00a0https:\/\/www.bisdro.uni-bremen.de\/boellinger\/cannabis\/08-zi-mo.pdf<\/a><\/p>\r\n\r\n\r\n\r\n

[586]<\/sup><\/a>\u00a0L. Lemberger et al. 1973. Comparative pharmacology of delta-9-THC and its metabolite 11-0H-Delta-9-THC.\u00a0Journal of Clinical Investigation<\/em>\u00a054: 2411-2417.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4729039<\/a><\/p>\r\n\r\n\r\n\r\n

M. Perez-Reyes et al. 1972.\u00a0Intravenous injection in man of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol.\u00a0Science<\/em>\u00a0177: 633-635.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4558903<\/a>\u00a0\u00a0<\/p>\r\n\r\n\r\n\r\n

[587]<\/sup><\/a>\u00a0L. Growing et al. 1998. Therapeutic use of cannabis: clarifying the debate.\u00a0Drug and Alcohol Review.<\/em>\u00a017: 445-452.\u00a0https:\/\/www.researchgate.net\/publication\/237718296_Drug_and_Alcohol_Services_Council_DASC_South_Australia_Therapeutic_Uses_of_Cannabis<\/a><\/p>\r\n\r\n\r\n\r\n

[588]<\/sup><\/a>\u00a0J. Morgan and L. Zimmer,\u00a0Marijuana Myths, Marijuana Facts: A Review of the Scientific Evidence,<\/em>\u00a019.\u00a0https:\/\/www.bisdro.uni-bremen.de\/boellinger\/cannabis\/08-zi-mo.pdf<\/a><\/p>\r\n\r\n\r\n\r\n

[589]<\/sup><\/a>\u00a0G. Carter et al. 2004. Medical marijuana: emerging applications for the management of neurologic disorders.\u00a0https:\/\/europepmc.org\/abstract\/med\/15458761<\/a>\u00a0\u00a0<\/p>\r\n\r\n\r\n\r\n

A. Zuardi et al. 1982. Action of cannabidiol on the anxiety and other effects produced by delta-9-THC in normal subjects.\u00a0Psychopharmacology<\/em>\u00a076: 245-250.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6285406<\/a><\/p>\r\n\r\n\r\n\r\n

G. Karinol et al. 1974. Cannabidiol interferes with the effects of delta-9-tetrahydrocannabinol in man.\u00a0European Journal of Pharmacology<\/em>\u00a028: 172-177.\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/0014299974901290<\/a><\/p>\r\n\r\n\r\n\r\n

[590]<\/sup><\/a>\u00a0D. Gieringer et al. 2004. Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds.\u00a0Journal of Cannabis Therapeutics<\/em>\u00a04: 7-27.\u00a0https:\/\/www.tandfonline.com\/doi\/abs\/10.1300\/J175v04n01_02<\/a><\/p>\r\n\r\n\r\n\r\n

[591]<\/sup><\/a>\u00a0L. Growing et al. 1998. Therapeutic use of cannabis: clarifying the debate.\u00a0Drug and Alcohol Review.<\/em><\/p>\r\n\r\n\r\n\r\n

[592]<\/sup><\/a>\u00a0National Academy of Sciences, Institute of Medicine. Of Marinol’s patient population, only about 10 percent use it to combat cancer-related nausea. 1999.\u00a0Marijuana and Medicine: Assessing the Science Base.<\/em>\u00a0p. 204.<\/p>\r\n\r\n\r\n\r\n

[593]<\/sup><\/a>\u00a0E. Woolridge et al. 2005. Cannabis use in HIV for pain and other medical symptoms.\u00a0Journal of Pain and Symptom Management<\/em>\u00a029: 358-67.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15857739<\/a><\/p>\r\n\r\n\r\n\r\n

[594]<\/sup><\/a>\u00a0J. McPartland and E. Russo. 2002. Cannabis and cannabis extracts: greater than the sum of their parts.\u00a0Journal of Cannabis Therapeutics.\u00a0https:\/\/www.researchgate.net\/publication\/228897917_Cannabis_and_cannabis_extracts_Greater_than_the_sum_of_their_parts<\/a><\/p>\r\n\r\n\r\n\r\n

[595]<\/sup><\/a>\u00a0Marijuana-like compound may aid array of debilitating conditions ranging from Parkinson’s Disease to pain. Society for Neuroscience. October 26, 2004.\u00a0ScienceDaily. ScienceDaily, 27 October 2004.\u00a0www.sciencedaily.com\/releases\/2004\/10\/041027102621.htm<\/a><\/p>\r\n\r\n\r\n\r\n

[596]<\/sup><\/a>\u00a0Pryce et al. 2003. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.\u00a0Brain<\/em>. 126: 2191-2202.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12876144<\/a><\/p>\r\n\r\n\r\n\r\n

[597]<\/sup><\/a>\u00a0C. Raman et al. 2004. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.\u00a0Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders<\/em>\u00a05: 33-39.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15204022<\/a><\/p>\r\n\r\n\r\n\r\n

[598]<\/sup><\/a>\u00a0I. Lastres-Becker et al. 2003.\u00a0Effects of cannabinoids in the rat model of Huntington’s disease generated by an intrastraital injection of malonate.\u00a0Neuroreport<\/em>\u00a014: 813-816.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12858038<\/a><\/p>\r\n\r\n\r\n\r\n

[599]<\/sup><\/a>\u00a0Ruth Gallily1, Zhannah Yekhtin1, Lum\u00edr Ond\u0159ej Hanu\u0161: Overcoming the Bell\u2010Shaped<\/p>\r\n\r\n\r\n\r\n

Dose\u2010Response of Cannabidiol by Using\u00a0Cannabis\u00a0<\/em>Extract Enriched in Cannabidiol. Pharmacology & Pharmacy, 2015, 6, 75\u201085. Published Online February 2015 in SciRes.\u00a0http:\/\/www.scirp.org\/journal\/pp<\/a>http:\/\/dx.doi.org\/10.4236\/pp.2015.62010<\/a><\/p>\r\n\r\n\r\n\r\n

Synthetic vs. Whole Plant CBD.\u00a0https:\/\/www.projectcbd.org\/article\/synthetic-vs-whole-plant-cbd<\/a><\/p>\r\n\r\n\r\n\r\n

[600]<\/sup><\/a>\u00a0Conditions.\u00a0https:\/\/www.projectcbd.org\/guidance\/conditions<\/a><\/p>\r\n\r\n\r\n\r\n

Taming THC.\u00a0https:\/\/www.projectcbd.org\/about\/cannabis-pharmacology\/taming-thc<\/a><\/p>\r\n\r\n\r\n\r\n

[601]<\/sup><\/a>\u00a0Tale of Two Cannabinoids.\u00a0https:\/\/www.projectcbd.org\/about\/cannabis-pharmacology\/tale-two-cannabinoids<\/a><\/p>\r\n\r\n\r\n\r\n

[602]<\/sup><\/a>\u00a0E. Williamson. 2001. Synergy and other interactions in phytomedicines.\u00a0Phytomedicine: International Journal of Phytotherapy and Phytopharmacology<\/em>\u00a08: 401-409.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11695885<\/a><\/p>\r\n\r\n\r\n\r\n

[603]<\/sup><\/a>\u00a0A. Holdcroft. 2001. Cannabinoids: from plant to patient.\u00a0Investigative Drugs Journal<\/em>. 4: 773-775.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15995932<\/a><\/p>\r\n\r\n\r\n\r\n

[604]<\/sup><\/a>\u00a0J. McPartland and E. Russo. 2002. Cannabis and cannabis extracts: greater than the sum of their parts.\u00a0Journal of Cannabis Therapeutics<\/em>. p. 103.\u00a0https:\/\/www.researchgate.net\/publication\/228897917_Cannabis_and_cannabis_extracts_Greater_than_the_sum_of_their_parts<\/a><\/p>\r\n\r\n\r\n\r\n

[605]<\/sup><\/a>\u00a0The Pharmaceutical Journal. “Cannabis herb may have advantages over THC in epilepsy.” July 19, 2003.<\/p>\r\n\r\n\r\n\r\n

[606]<\/sup><\/a>\u00a0D. Wade et al. 2004. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.\u00a0Multiple Sclerosis\u00a02004 Aug;10(4):434-41.\u00a0\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15327042<\/a><\/p>\r\n\r\n\r\n\r\n

J. Zajicek et al. 2003.\u00a0Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis. Lancet. 362: 1517-26.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14615106<\/a><\/p>\r\n\r\n\r\n\r\n

[607]<\/sup><\/a>\u00a0Paul Armentano:\u00a0Marinol Versus Natural Cannabis.\u00a0Pros, Cons and Options for Patients. The National Organization for the Reform of Marijuana Laws.\u00a0http:\/\/norml.org\/pdf_files\/NORML_Marinol_vs_Natural_Cannabis.pdf<\/a>\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\r\n\r\n\r\n\r\n

[608]<\/sup><\/a>\u00a0R. Musty and R. Rossi. 2001. Effects of smoked cannabis and oral delta-9-tetrahydrocannabinol on nausea and emesis after cancer chemotherapy: a review of state clinical trials.\u00a0Journal of Cannabis Therapeutics.<\/em>\u00a01: 29-56.\u00a0http:\/\/www.cannabis-med.org\/iacm\/data\/pdf\/2001-01-2.pdf<\/a><\/p>\r\n\r\n\r\n\r\n

[609]<\/sup><\/a>\u00a0Board of Pharmacy, State of Tennessee. 1983.\u00a0Annual Report: Evaluation of Marijuana and Tetrahydrocannabinol in Treatment of Nausea and\/or Vomiting Associated with Cancer Therapy Unresponsive to Conventional Anti-Emetic Therapy: Efficacy and Toxicity.\u00a0p. 5.\u00a0https:\/\/www.epistemonikos.org\/en\/documents\/0ae184c24b15d7d0e026fb727d608fdd07cc35ae<\/a><\/p>\r\n\r\n\r\n\r\n

[610]<\/sup><\/a>\u00a0Behavioral Health Services Division. 1983.\u00a0The Lynn Pierson Therapeutic Research Program: A Report on Progress to Date. Health and Environment Department: New Mexico. p. 4.\u00a0https:\/\/medicalmarijuana.procon.org\/sourcefiles\/new-mexico-progress-report-1983.pdf<\/a><\/p>\r\n\r\n\r\n\r\n

[611]<\/sup><\/a>\u00a0R. Schwartz and R. Beveridge. 1994. Marijuana as an antiemetic drug: how useful today. Opinions from clinical oncologists.\u00a0Journal of Addictive Diseases<\/em>\u00a013: 53-65.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7503819<\/a><\/p>\r\n\r\n\r\n\r\n

[612]<\/sup><\/a>\u00a0R. Doblin and M. Kleiman. 1991. Marijuana as an anti-emetic medicine: a survey of oncologists’ attitudes and experiences.\u00a0Journal of Clinical Oncology<\/em>\u00a019: 1275-1290.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2045870<\/a><\/p>\r\n\r\n\r\n\r\n

[613]<\/sup><\/a>\u00a0Research Advisory Panel. 1986.\u00a0Seventeenth Annual Report of the Research Advisory Panel,\u00a0p. 9-10.<\/p>\r\n\r\n\r\n\r\n

[614]<\/sup><\/a>\u00a0V. Vinciguerra et al. 1988. Inhalation marijuana as an antiemetic for cancer chemotherapy.\u00a0New York State Journal of Medicine\u00a088: 525-527.\u00a0https:\/\/www.researchgate.net\/publication\/19925671_Inhalation_marijuana_as_an_antiemetic_for_cancer_chemotherapy<\/a><\/p>\r\n\r\n\r\n\r\n

[615]<\/sup><\/a>\u00a0E. Woolridge et al. 2005. Cannabis use in HIV for pain and other medical symptoms.\u00a0Journal of Pain and Symptom Management.<\/em>\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15857739<\/a><\/p>\r\n\r\n\r\n\r\n

[616]<\/sup><\/a>\u00a0D. Prentiss et al. 2004. Patterns of marijuana use among patients with HIV\/AIDS followed in a public health care setting.\u00a0Journal of Acquired Immune Definiciency Syndromes<\/em>\u00a035: 38-45.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14707790<\/a><\/p>\r\n\r\n\r\n\r\n

[617]<\/sup><\/a>\u00a0R. Gorter et al. 2005. Medical use of cannabis in the Netherlands.\u00a0Neurology<\/em>\u00a064: 917-919.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15753439<\/a><\/p>\r\n\r\n\r\n\r\n

[618]<\/sup><\/a>\u00a0Reuters News Wire. “Marijuana helps MS patients alleviate pain, spasms.” August 19, 2002.<\/p>\r\n\r\n\r\n\r\n

Multiple Sclerosis.\u00a0http:\/\/norml.org\/library\/item\/multiple-sclerosis#b20<\/a><\/p>\r\n\r\n\r\n\r\n

[619]<\/sup><\/a>\u00a0S. Page et al. 2003. Cannabis use as described by people with multiple sclerosis.\u00a0Canadian Journal of Neurological Sciences\u00a030: 201-205.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12945941<\/a><\/p>\r\n\r\n\r\n\r\n

[620]<\/sup><\/a>\u00a0A. Clark et al. 2004. Patterns of cannabis use among patients with multiple sclerosis.\u00a0Neurology<\/em>\u00a062: 2098-2100.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15184623<\/a><\/p>\r\n\r\n\r\n\r\n

[621]<\/sup><\/a>\u00a0D. Gross et al. 2004. Marijuana use and epilepsy.\u00a0Neurology<\/em>\u00a062: 2095-2097.\u00a0http:\/\/n.neurology.org\/content\/62\/11\/2095<\/a><\/p>\r\n\r\n\r\n\r\n

[622]<\/sup><\/a>\u00a0News Wire. “Pot may ease Parkinson’s symptoms — Czech study.” November 13, 2002.<\/p>\r\n\r\n\r\n\r\n

[623]<\/sup><\/a>\u00a0Hazekamp A<\/a>1<\/sup>,\u00a0Ware MA<\/a>,\u00a0Muller-Vahl KR<\/a>. et al.: The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms.\u00a0J Psychoactive Drugs.<\/a>\u00a02013 Jul-Aug;45(3):199-210.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24175484<\/a><\/p>\r\n","protected":false},"excerpt":{"rendered":"

[524]\u00a010 Cannabis-Based Drugs Produced By Big Pharma.\u00a0https:\/\/herb.co\/marijuana\/news\/cannabis-based-drugs-big-pharma [525]\u00a0Dagfinn Haarr, Sofie Haughom: Marihuana er effektiv medisin.http:\/\/www.aftenposten.no\/meninger\/kronikker\/Kronikk-Marihuana-er-effektiv-medisin—Dagfinn-Haarr_-Sofie-Haughom-8378238.html [526]\u00a0Cannabis f\u00e5r kr\u00e6ftceller til at beg\u00e5 selvmord.\u00a0http:\/\/www.ladanesa.com\/temaadebat\/43-nyheder\/temaadebat\/4818-cannabis-far-kraeftceller-til-at-bega-selvmord [527]\u00a0What Are The Medical Benefits of Marijuana?\u00a0https:\/\/www.leafscience.com\/2017\/10\/13\/medical-benefits-marijuana\/ What Exactly Is Unconstitutional About Plans To Limit THC?\u00a0https:\/\/herb.co\/marijuana\/news\/what-exactly-is-unconstitutional-about-plans-to-limit-thc What is … L\u00e6s resten →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-42","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/42","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/comments?post=42"}],"version-history":[{"count":3,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/42\/revisions"}],"predecessor-version":[{"id":910,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/42\/revisions\/910"}],"wp:attachment":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/media?parent=42"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}